[Stereotactic radiotherapy for localized primary lung tumours of stage T1-T2].
Fiche publication
Date publication
septembre 2022
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MARTIN Etienne
Tous les auteurs :
Boisselier P, Coutte A, Martin E, Pointreau Y
Lien Pubmed
Résumé
The historical treatment for stage I non-small cell lung cancer is surgical. Parenchymal amputation is not always possible due to cardiopulmonary comorbidities and stereotactic radiotherapy is one of the alternatives to an invasive procedure. The excellent results observed for inoperable tumors raised the question of this treatment in operable patients. This article presents the data in these two situations and the future perspectives.
Mots clés
Cancer du poumon, Early stage, Lung cancer, Radiothérapie stéréotaxique, Stade localisé, Stereotactic body radiotherapy
Référence
Cancer Radiother. 2022 09 5;: